Immunology podcasts

Vincent Racaniello, Alan Dove and Brianne Barker discuss a newly identified mechanism for RNA-guided DNA recognition and genetic control that may predate CRISPR pathways. They also examine research proposing that features of Alzheimer’s disease neuropathology could have originated as a host response to infection in the brain, including evidence concerning phosphorylated tau and herpesvirus activity. The episode connects ancient molecular recognition mechanisms with questions about antiviral defence.

Hosted by Vincent Racaniello, Alan Dove

Adrian Hill discusses the scientific challenges behind developing the R21/Matrix-M malaria vaccine, its path from research to use, and efforts to make vaccination accessible in Africa. The conversation explores the complexity of the malaria parasite and the practical demands of vaccine production and delivery. The publisher credits Marushka Soobben and Chris Smith as presenters and provides the episode audio and interview transcript.

Hosted by Marushka Soobben, Chris Smith

The Chemistry World team examines research on CAR-T immunotherapy for bladder tumours, including results in mice and the challenges of treating solid cancers. A second discussion considers how incorrectly assigned spectral features may have affected interpretations of defects in carbon materials.

Hosted by Mariana Kneppers

Nature reporters discuss Dolly Parton's advocacy for vaccines and public health alongside promising phase III results for a personalised mRNA cancer vaccine for melanoma.

Andrew Huberman and immunologist Max Krummel discuss immune function, sleep, emotions, memory, the thymus, autoimmunity, cancer and immunization.

Gunnveig Grødeland discusses progress and concerns during the initial COVID-19 vaccine rollout. This Norwegian archive episode reflects evidence available at publication.

Gunnveig Grødeland explains vaccine development and immune protection during the COVID-19 pandemic. The Norwegian discussion reflects its original publication period.

Anne Spurkland returns to discuss evolving knowledge about COVID-19 and efforts to develop treatments and vaccines. This Norwegian episode records a 2020 perspective.

Anne Spurkland discusses coronavirus biology, transmission and responses to the emerging pandemic. This Norwegian conversation reflects knowledge at its original 2020 publication date.